Data accumulated in CURES[1] is available to appropriate state and federal agencies, law enforcement, and regulatory boards for disciplinary, civil, or criminal purposes. But when should CURES be reviewed for such purposes? When a government suspects overprescribing? May it be used against a prescriber or a pharmacist when no controlled substances are involved in the
DEA and Controlled Substances
DEA’s investigations of pharmacies and wholesalers have increased
By Natalia Mazina on
Posted in DEA and Controlled Substances
The DEA has recently audited several large pharmacies and drug wholesalers finding substantial non-compliance with the Controlled Substances Act (CSA). The non-compliance has resulted in large settlements, corrective action plans, and some business restructuring. The examples below concentrate on major pharmacy chains and large wholesalers, however, a number of smaller pharmacies and wholesalers have settled …